USPTO serial 99825491
SOONR
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- STADELI, MARTA ANN
- Law office
- TMO LAW OFFICE 123
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with SOONR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, Deluca, & Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Ovulation test kits; Diagnostic reagents for medical use; Pregnancy test kits for home use; Reagents for use in diagnostic pregnancy tests for medical purposes; Diagnostic reagents for medical use in in vitro diagnosis; Medical diagnostic assays for analyzing female hormones for medical use; Medical diagnostic assays for analyzing pregnancy, ovulation and menopausal status for medical use; Medical diagnostic assays for analyzing women's fertility for home use; Medical diagnostic assays for analyzing male infertility; Medical diagnostic reagents for use in sperm testing; Medical diagnostic test strips for in vitro diagnosis for evaluation of pregnancy, ovulation and menopausal status for medical use; Medical diagnostic test strips for in vitro diagnosis for women’s fertility; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids | ACTIVE | — |
| 009 | (Based on Use) Downloadable computer application software for smartphones, namely, software for providing personalized health care information; Downloadable computer software for providing health care information; Downloadable computer programs for network management; Downloadable computer software for providing menstrual health care information; Downloadable computer software for mobile terminals; Downloadable computer programs for providing human hormone management information; Computer operating programs, recorded; Data processing apparatus; Downloadable multimedia files containing artwork, text, audio, video, games, and Internet Web links relating to women's and men's health, hormonal health, menstrual cycle management, reproductive health, and fertility; Recorded computer software platforms for data processing; Downloadable computer software for database management; Downloadable computer software for wireless content delivery for smartphones; Downloadable computer software for diagnosing diseases for medical purposes; Downloadable computer software for medical decision support systems; Downloadable computer application software for mobile phones, namely, software for menstrual cycle and ovulation prediction; Downloadable computer application software for mobile phones, namely, software for pregnancy probability and fertile period prediction; Downloadable computer software for collection, storage, analysis and visualization of measurement data of female hormones and biomarkers; Downloadable computer software for health data analysis interoperable with in vitro diagnostic medical devices and wearable devices; Downloadable computer software for analysis and provision of biometric signals and hormone data, interoperable with remote servers; Downloadable text files relating to wellness reports; Recorded computer software for for providing personalized health care information, for diagnosing diseases for medical purposes, for medical decision support systems (Based on Intent to Use) Recorded computer software for wearable devices for biomarker measurement; Recorded computer software for control of test readers for in vitro diagnosis; Wearable activity trackers; Scientific instrumentation for measuring of biometric signals and biomarkers; Scientific instrumentation for measuring heart rate, body temperature and skin electrical response; Scientific instrumentation for measuring biomarkers for monitoring of women's menstrual cycle and ovulation status; Sensors for measuring test sticks for in vitro diagnosis, not for medical use; Sensors for measuring biomarkers, body temperature, heart rate, galvanic skin response, and reproductive health indicators, not for medical use; Optical sensors; Wearable computers in the nature of smartwatches; Wrist-mounted smartphones; Downloadable image files containing health data reports, biomarker analysis results, and wellness information relating to women's and men's hormonal health and reproductive health; Prerecorded digital video disks featuring motion picture films; Smart rings; Medical laboratory research instruments for detecting analytes in biological samples | ACTIVE | Feb 13, 2026 |
| 010 | Medical apparatus and instruments for monitoring hormones; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring liquid flow measurement; Medical apparatus and instruments for monitoring in vitro diagnosis; Medical products, namely, biofeedback sensors; Electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; Patient monitoring sensors and alarms; Medical apparatus and instruments for monitoring in vitro diagnostic test sticks for women's and men's reproductive health assessment with built-in optical elements; Medical apparatus and instruments for monitoring examination of male reproductive organs; Diagnostic apparatus for medical purposes for use in medical laboratories for testing urine; Diagnostic apparatus for medical purposes for use in medical laboratories for testing sperm | ACTIVE | — |
| 042 | Computer software consultancy; Medical and scientific research in the field of healthcare and healthcare data | ACTIVE | — |
| 044 | Medical services; Medical consultations; Medical clinic services; Provision of medical information; Physical examination services; Healthcare | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vespexx Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SOONR
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 15, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 15, 2026 | NWAP | NEW APPLICATION ENTERED | — |